Showing results (31-40 of 98) with videos related to
Sort By:
Pageof 10
Analytical Chemistry|November 13, 2025
Quantitative Assessment of the Target Engagement of a KRAS G12C Inhibitor in Formalin-Fixed Paraffin-Embedded Tumor Tissues Using Immunoaffinity Capture 2D-LC-MS/MSAiying Yu, Jintang He, Lingyao Meng, et al.Inflammation|May 12, 2026
Erosion or Explosion: Integrated Single-Cell Transcriptomics Reveals Cellular Heterogeneity in Aortic Aneurysm and DissectionHeng Wang, Keyi Fan, Yaling Li, et al.The AAPS Journal|December 19, 2023
Novel Selective Quantification of Zinpentraxin Alfa Biotherapeutic in the Presence of Endogenous Isomer in Plasma Samples of Idiopathic Pulmonary Fibrosis Patients Using Immunoaffinity LC-MSMaoyin Li, Audrey Arjomandi, Xiaowei Sun, et al.Bioanalysis|May 7, 2013
Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serumKeyang Xu, Luna Liu, Randall Dere, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 29, 2019
Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic studyKeyang Xu, Xu Zhao, Xiaoqing Fu, et al.ACS Nano|March 26, 2025
Iron Homeostasis-Regulated Adaptive Metabolism of PEGylated Ultrasmall Iron Oxide NanoparticlesNing Wang, Dandan Zhou, Keyang Xu, et al.Cytotechnology|April 27, 2020
Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in miceShourong Liu, Ruihong Guo, Xiaoli Hou, et al.Bioanalysis|November 18, 2021
Challenges with development of a pharmacokinetics assay to measure a variably glycosylated fusion proteinGizette Sperinde, Luna Liu, Keyang Xu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2022
A Cross Company Perspective on the Assessment of Therapeutic Protein BiotransformationMarkus Walles, Michael Berna, Wenying Jian, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 9, 2022
Morroniside, a novel GATA3 binding molecule, inhibits hepatic stellate cells activation by enhancing lysosomal acid lipase expressionLin An, Mi Zhang, Yuefang Lin, et al.Pageof 10